Regado Biosciences, Inc. Selects TransPerfect Trial Interactive Platform as its Study Start-Up and eTMF Solution
Published: Oct 21, 2013
NEW YORK--(BUSINESS WIRE)--TransPerfect, a leading provider of e-clinical solutions to the life sciences industry, today announced that Regado Biosciences has implemented TransPerfect’s Trial Interactive solution to streamline study start-up and electronic trial master file (eTMF) management for its ongoing 500-site Phase III global study (REGULATE-PCI). Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that eliminates the redundancies inherent in paper-based management of clinical trials.
Help employers find you! Check out all the jobs and post your resume.